Key result
CV 6209 acted as a competitive antagonist of Paf receptors in rabbit platelets and PMN, but as a non-competitive antagonist of Paf-induced PGI2 generation in guinea-pig macrophages.
CV 6209 acts as a non-competitive antagonist of Paf receptors on guinea-pig macrophages, suggesting these receptors are distinct from those mediating platelet and PMN aggregation.
CV 6209's cell-specific antagonism leaves open distinct Paf receptor subtypes; animal data alone warrant no clinical extrapolation.
The characteristics of antagonism of platelet-activating factor (Paf) receptors by the phospholipid Paf analogue, CV 6209, were studied in rabbit platelets and polymorphonuclear leucocytes (PMN) and in guinea-pig macrophages. 2. Paf-induced aggregation of PMN or platelets was antagonized in a competitive and specific manner by CV 6209 with no detectable difference between the pA2 values (approximately 9.5). 3. The specificity of CV 6209 (1-100 nmol/L) for Paf receptors in platelets and PMN was indicated by a lack of effect on A23187 (10 mumols/L) or fMLP (1 mumol/L) induced aggregation, respectively. 4. CV 6209 (1-100 nmol/L) was also a potent antagonist of Paf-induced prostacyclin (PGI2) generation by guinea-pig peritoneal macrophages. However, CV 6209 caused significant depression of the maximum response to Paf and a non-parallel shift in the concentration-response curve indicating a non-competitive type antagonism. 5. PGI2 generation induced by the ionophore A23187 was unaffected by CV 6209 (up to 100 nmol/L) whereas basal PGI2 production by macrophages was reduced by lower concentrations (10-100 nmol/L). These observations are not consistent with a direct effect of CV 6209 on the enzymes involved in PGI2 synthesis but do suggest that endogenous Paf regulates basal PGI2 generation. 6. The non-competitive antagonism of guinea-pig macrophage Paf receptors gives further support to the contention that these receptors are distinct from those mediating aggregation of platelets and PMN.
No takes yet. Share an insight, caveat, or question.
Alastair G. Stewart (1989) studied this question. CV 6209 was evaluated on Paf-induced aggregation and PGI2 generation. CV 6209 acted as a competitive antagonist of Paf receptors in rabbit platelets and PMN, but as a non-competitive antagonist of Paf-induced PGI2 generation in guinea-pig macrophages.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: